Published in PLoS One on November 29, 2013
Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharmacol Toxicol (2014) 1.04
Eph receptor tyrosine kinases in cancer stem cells. Cytokine Growth Factor Rev (2014) 0.84
EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell. Sci Rep (2015) 0.84
Axon guidance in the auditory system: multiple functions of Eph receptors. Neuroscience (2014) 0.81
Unliganded EphA3 dimerization promoted by the SAM domain. Biochem J (2015) 0.80
Promiscuous and specific recognition among ephrins and Eph receptors. Biochim Biophys Acta (2014) 0.79
Eph-ephrin signaling in nervous system development. F1000Res (2016) 0.79
Homotypic receptor-receptor interactions regulating Eph signaling. Cell Adh Migr (2014) 0.78
Ephrin-A2 and ephrin-A5 guide contralateral targeting but not topographic mapping of ventral cochlear nucleus axons. Neural Dev (2015) 0.76
Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions. Structure (2015) 0.76
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants. Growth Factors (2014) 0.76
A molecular mechanism for the topographic alignment of convergent neural maps. Elife (2017) 0.75
Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion. PLoS Pathog (2016) 0.75
Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer. Oncotarget (2016) 0.75
EphA4 Regulates Neuroblast and Astrocyte Organization in a Neurogenic Niche. J Neurosci (2017) 0.75
Asymmetry at cell-cell interfaces direct cell sorting, boundary formation, and tissue morphogenesis. Exp Cell Res (2017) 0.75
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell (2002) 8.08
Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol (2005) 7.14
Eph-ephrin bidirectional signaling in physiology and disease. Cell (2008) 7.12
Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer (2010) 5.26
The ephrins and Eph receptors in neural development. Annu Rev Neurosci (1998) 5.07
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev (2005) 3.29
Regulated cleavage of a contact-mediated axon repellent. Science (2000) 3.24
Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell (2005) 2.88
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol (2006) 2.87
Crystal structure of an Eph receptor-ephrin complex. Nature (2002) 2.80
A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell (2005) 2.27
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol (2001) 2.25
The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res (2008) 2.21
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A (2004) 2.01
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ (1999) 2.01
Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron (2011) 2.00
Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons. Neuron (1999) 1.97
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol (2010) 1.89
Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci (2006) 1.86
Generation of HIV-1 derived lentiviral vectors. Methods Enzymol (2002) 1.81
An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol (2010) 1.80
Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets (2011) 1.65
Paradoxes of the EphB4 receptor in cancer. Cancer Res (2007) 1.58
c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res (2002) 1.57
EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res (2006) 1.50
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell (2013) 1.44
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood (2009) 1.38
B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature (1994) 1.37
Eph receptor signaling and ephrins. Cold Spring Harb Perspect Biol (2013) 1.33
CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev (2009) 1.24
EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci Res (2004) 1.19
Eph receptors and Ephrins in cancer: common themes and controversies. Cancer Res (2008) 1.17
Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Cell Signal (2010) 1.08
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nat Commun (2012) 1.03
Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. Cell Adh Migr (2012) 1.02
Effects of cancer-associated EPHA3 mutations on lung cancer. J Natl Cancer Inst (2012) 1.02
EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Res (2011) 1.02
TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Curr Opin Immunol (2011) 1.01
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry (2012) 1.01
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol (2011) 1.00
The cis side of juxtacrine signaling: a new role in the development of the nervous system. Trends Neurosci (2012) 0.99
EphA2-dependent molecular targeting therapy for malignant tumors. Curr Cancer Drug Targets (2011) 0.94
Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers. Exp Cell Res (2007) 0.92
Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival. J Gastroenterol (2012) 0.92
EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol (2012) 0.91
Ephrin-B3 regulates glutamate receptor signaling at hippocampal synapses. Mol Cell Neurosci (2010) 0.90
Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells. Cancer Cell Int (2010) 0.89
Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor. J Proteome Res (2011) 0.89
Ephrin-B3 binds to a sulfated cell-surface receptor. Biochem J (2011) 0.83
EPHA3 as a novel therapeutic target in the hematological malignancies. Expert Rev Hematol (2012) 0.83